The BRAIN Act (Bolstering Research And Innovation Now Act)
April 9, 2025
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
Where This Stands
Currently in_committee. The next step in the legislative lifecycle is Floor Vote.
Version history
Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.
View official text →The Frame
This bill would direct $50 million annually from 2026 to 2030 toward research and establish new reporting requirements for researchers holding NIH-funded brain tumor samples.
Potentially affected actors named in the source documents. Mention is not a position.
Brain tumor patients and survivors
Patients may see increased availability of clinical trials and improved long-term monitoring programs.
Medical research institutions
Institutions holding NIH-funded biospecimens must comply with new reporting requirements or risk losing federal funding.
National Institutes of Health (NIH)
The agency is tasked with managing new research networks, maintaining public databases, and enforcing reporting compliance.
Current stage: in_committee.
Floor Vote.
Summary
Key Facts
- Authorizes $50 million in annual appropriations for fiscal years 2026 through 2030 for the Glioblastoma Therapeutics Network.
- Requires individuals or entities holding NIH-funded brain tumor biospecimens to report them to the NIH within 180 days of enactment.
- Requires reporting of new NIH-funded biospecimen collections within 60 days of acquisition.
- Directs the NIH to establish a searchable public website for information on existing brain tumor biospecimen collections.
- Authorizes the NIH to withhold funding from entities that repeatedly or egregiously fail to report biospecimen collections.
- Establishes a 'Glioblastoma Therapeutics Network' to evaluate therapeutic agents from pre-clinical development through early-phase human trials.
- Creates a 'Team Science Award' to support multi-institutional research into cellular immunotherapy (including CAR-T) for brain tumors.
- Directs the FDA to issue guidance aimed at ensuring brain tumor patient access to clinical trials.
- Mandates a national public awareness campaign regarding cancer clinical trials and biomarker testing.
- Requires the development of pilot programs to study and improve monitoring and care for brain tumor survivors.
Why It Matters
This bill would direct $50 million annually from 2026 to 2030 toward research and establish new reporting requirements for researchers holding NIH-funded brain tumor samples.
Frequently Asked Questions
What is the main goal of the BRAIN Act?
How will the bill affect researchers who have brain tumor samples?
What is the Glioblastoma Therapeutics Network?
News Coverage
Lobbying Activity
The Cleveland Clinic Foundation
on behalf of Cleveland Clinic Foundation
2026
“Quantum computing Immigration Issues National Institute of Health CHILDReN Act EARLY Minds Act Interoperability Issues Brain Health 340B Graduate Medical Education Workforce Issues Payer Accountability Organ Transplant Legislation Healthy Competition Act Price Transparency ”
HEALTH AND MEDICINE COUNSEL, LLC
on behalf of VOICES AGAINST BRAIN CANCER
Cleveland Clinic Foundation
2024
“Telehealth Artificial intelligence Quantum legislation National Institutes of Health Reform Medical Nutrition Therapy Act The REDUCE Act Amputation Reduction and Compassion Act Affordable housing School-based health Food insecurity Breast cancer innovation Traumatic Brain Injury Technology Graduate Medical Education Reform Wage index Tax Exempt Status ”
Cleveland Clinic Foundation
on behalf of The Cleveland Clinic Foundation
2022
“SANE Act Telehealth (H.R.4040) Hospital-at-Home Food insecurity NQF Funding Brain Health NIH Reform No Surprise Act implementation ”
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Increased Oversight of Research Samples
The bill marks a shift toward mandatory public disclosure and centralized tracking of NIH-funded biospecimens.
Connected Entities
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz30Current news / social attention level
Publisher tools